🇺🇸 FDA
Pipeline program

Lapaquistat acetate and atorvastatin

01-04-TL-475-009

Phase 3 small_molecule completed

Quick answer

Lapaquistat acetate and atorvastatin for Hypercholesterolemia is a Phase 3 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 2 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Hypercholesterolemia
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials